Cargando…
Leptin Receptors Are Not Required for Roux-en-Y Gastric Bypass Surgery to Normalize Energy and Glucose Homeostasis in Rats
Sensitization to the adipokine leptin is a promising therapeutic strategy against obesity and its comorbidities and has been proposed to contribute to the lasting metabolic benefits of Roux-en-Y gastric bypass (RYGB) surgery. We formally tested this idea using Zucker fatty fa/fa rats as an establish...
Autores principales: | Hankir, Mohammed K., Rotzinger, Laura, Nordbeck, Arno, Corteville, Caroline, Dischinger, Ulrich, Knop, Juna-Lisa, Hoffmann, Annett, Otto, Christoph, Seyfried, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147759/ https://www.ncbi.nlm.nih.gov/pubmed/34064308 http://dx.doi.org/10.3390/nu13051544 |
Ejemplares similares
-
Toward a Medical Gastric Bypass: Chronic Feeding Studies With Liraglutide + PYY(3-36) Combination Therapy in Diet-Induced Obese Rats
por: Dischinger, Ulrich, et al.
Publicado: (2021) -
Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats
por: Dischinger, Ulrich, et al.
Publicado: (2021) -
Leptin Is Required for Glucose Homeostasis after Roux-en-Y Gastric Bypass in Mice
por: Mokadem, Mohamad, et al.
Publicado: (2015) -
Roux-en-Y gastric bypass surgery in Zucker rats induces bacterial and systemic metabolic changes independent of caloric restriction-induced weight loss
por: Seyfried, Florian, et al.
Publicado: (2021) -
Liraglutide + PYY(3-36) Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements
por: Metzner, Valentin, et al.
Publicado: (2022)